Xenogeneic Testicular Cell Vaccination Induces Long-Term Anti-Cancer Immunity in Mice

Xenogeneic Testicular Cell Vaccination Induces Long-Term Anti-Cancer Immunity in Mice

Cancer/testis antigen (CTA) gene products are expressed in most malignant tumours, while under normal conditions their expression is primarily restricted to testicular cells. In this study, we investigated the prophylactic application of a xenogeneic (ram-derived) testicular cell (TC) vaccine for ca...

Full description

Saved in:

Bibliographic Details
Main Authors:	Victor I. Seledtsov, Ayana B. Dorzhieva, Adas Darinskas, Alexei A. von Delwig, Elena A. Blinova, Galina V. Seledtsova
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Current Issues in Molecular Biology
Subjects:	cancer vaccine cancer/testis antigens xenogeneic vaccination cancer immunity carcinoma melanoma
Online Access:	https://www.mdpi.com/1467-3045/47/6/443
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The use of xenogenic testicular antigens for induction of antitumor reactions
by: G. V. Seledtsova, et al.
Published: (2024-01-01)

ANALYSIS OF CANCER-TESTIS ANTIGENS AS POTENTIAL MARKERS FOR DISSEMINATION OF PRIMARY HUMAN SKIN MELANOMA
by: I. N. Mikhaylova, et al.
Published: (2021-06-01)

Comparative analysis of hemodynamic characteristics of the biological xenogenic pericardial prosthesis MEDINGE-BIO with “easy change” system and the xenogenic aortic prosthesis Hancock II after aortic valve replacement
by: K. A. Petlin, et al.
Published: (2021-09-01)

Tumour-Derived, Extracellular Microvesicles in the Treatment of Acute Renal Failure: An Experimental Study
by: Galina V. Seledtsova, et al.
Published: (2025-04-01)

Nanoliposome-encapsulated MAGE peptides: A promising melanoma vaccine to activate human dendritic cells
by: Azin Bavafa, et al.
Published: (2025-05-01)

Generation of mouse and rat xenogeneic ovaries in vitro for production of mouse oocyte
by: Si Won Jang, et al.
Published: (2024-12-01)

CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01)

Characteristics of adaptive immune effectors involved in the secondary xenogeneic immune response to human melanoma cells
by: N. A. Persiyantseva, et al.
Published: (2023-12-01)

Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors
by: Rebecca R. J. Collins, et al.
Published: (2025-07-01)

Xenogeneic bone mineral is efficient for the repair of critical-sized rat calvarial defects
by: A. V. Veremeev, et al.
Published: (2021-03-01)

VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens
by: Ibel Carri, et al.
Published: (2025-01-01)

Challenges and New Directions in Therapeutic Cancer Vaccine Development
by: Danjie Pan, et al.
Published: (2024-11-01)

Relationship between the transcriptional activity of СT-genes and survival in colorectal cancer patients
by: D. S. Kutilin, et al.
Published: (2022-03-01)

Long-term results of aortic valve replacement with xenogenic pericardial stentless prosthesis BioLAB KB/A
by: S. I. Babenko, et al.
Published: (2020-12-01)

Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23
by: Xia Zeng, et al.
Published: (2023-12-01)

IMMUNOTHERAPY FOR MELANOMA
by: E. A. Borobova, et al.
Published: (2017-09-01)

Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis
by: Lina Lin, et al.
Published: (2021-12-01)

Detecting Predicted Cancer-Testis Antigens in Proteomics Datasets of Healthy and Tumoral Samples
by: Karla Cristina Tabosa Machado, et al.
Published: (2024-01-01)

Regenerative and hepatospecific activity of total RNA from xenogenic bone marrow cells
by: N. A. Onishchenko, et al.
Published: (2021-04-01)

Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery
by: Ibeanu GC, et al.
Published: (2024-12-01)

Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition
by: Mie K. Jakobsen, et al.
Published: (2025-01-01)

To the Mechanism of Adrenaline Damage to the Heart Tissue and the Mechanism of Cardioprotection by Neonatal, Xenogenic, Cardiac Cells. Dynamics of Creatine Phosphate, Lactate and Malondialdehyde
by: S. L. Bogorodskaya, et al.
Published: (2021-01-01)

IMMUNE AND METABOLIC DISTURBANCES IN EXPERIMENTAL ACUTE TOXIC HEPATITIS: CORRECTION BY XENOGENIC AND ALLOGENIC HEPATOCYTES
by: A. I. Konoplya, et al.
Published: (2016-06-01)

CRISPR/dCas-mediated counter-silencing: reprogramming dCas proteins into antagonists of xenogeneic silencers
by: Johanna Wiechert, et al.
Published: (2025-07-01)

Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers
by: Hiroki Kinoshita, et al.
Published: (2025-03-01)

Targeted Delivery of Personalized Cancer Vaccines Based on Antibody–Antigen Complexes
by: Yaling Zhang, et al.
Published: (2025-03-01)

Efficacy of xenogeneic fresh and lyophilized amniotic membranes on the healing of experimentally induced full-thickness skin wounds in dogs
by: Kamal H. Hussein, et al.
Published: (2025-05-01)

‘Lamina External Graft Overlay’: The Use of Segmented Xenogenic Bone Sheets in the Reconstruction of 3D Bone Defects
by: Roberto Rossi, et al.
Published: (2025-04-01)

Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives
by: Ayesha Zahid, et al.
Published: (2025-07-01)

Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01)

Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
by: Spencer G. Van Decar, et al.
Published: (2024-01-01)

Neo-antigen specific cancer vaccines for acute lymphoblastic leukemia—challenges, opportunities, and future directions
by: Victoria Bloch Blytt Sandstad, et al.
Published: (2025-06-01)

Recent progress in mRNA cancer vaccines
by: Ruhui Yao, et al.
Published: (2024-12-01)

Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against KitK641E-mutant melanoma
by: Kishwor Poudel, et al.
Published: (2025-04-01)

Unraveling the power of NAP-CNB’s machine learning-enhanced tumor neoantigen prediction
by: Almudena Mendez-Perez, et al.
Published: (2025-03-01)

STUDY OF DENDRITIC CELL MIGRATION USING CELL-IQ ANALYSIS SYSTEM
by: T. L. Nekhaeva, et al.
Published: (2018-09-01)

Cancer-testis antigen MAGE-C1/ CT7 in multiple myeloma: literature review
by: E. A. Makunina
Published: (2020-12-01)

FEATURES OF THE IMMUNE RESPONSE TO XENOGENIC TISSUES OF VALVES AND PATCHES OF THE HEART (literature review)
by: Andrey Vladimirovich Shabaldin, et al.
Published: (2019-08-01)

Unlocking cancer vaccine potential: What are the key factors?
by: Michael Grant, et al.
Published: (2024-12-01)

Mesenchymal stromal cells 2.0: thinking outside the box
by: Gabrielle A. Mandl, et al.
Published: (2025-08-01)